CORE--BLOOD AND TISSUE SPECIMEN
核心——血液和组织样本
基本信息
- 批准号:6824633
- 负责人:
- 金额:$ 16.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): This Core will serve as a vital resource center for blood and tissue-based studies integral to the completion of investigational projects, related to aggressive, interventional treatment of cerebral hemorrhage and ischemic infarcts. It will bring to analyses of blood and tissues derived from study patients a wealth of expertise in morphoanatomical techniques pertinent to stroke pathogenesis, and provide access to key investigators of samples of brain tissue derived from biopsy and autopsy specimens of study patients. The core will support Project 1, the MR RESCUE trial, in which intravascular thrombus material will be removed in the course of therapeutic thrombectomy. The core will assist investigators studying the biochemical pathogenesis of thrombus formation, and its possible importance in evolution of cerebral infarcts, and will assist investigators in correlating their findings with light microscopic/ultrastructural features of the thrombi. The core will also
provide support to Project 2, the HEME Surgery trial, in which brain tissue originating from 'clot'
evacuations carried out in patients with spontaneous intracerebral (parenchymal) hemorrhage will be carefully evaluated for both the likely etiology of hemorrhage and the tissue response to intracerebral blood, and readied for studies of differential gene expression employing qualitative, real-time RT-PCR and cDNA arrays. The Core will store blood samples from appropriate patients for DNA analysis, and provide these to researchers following appropriate review of their investigational goals and projects. The Core will serve as an important 'blood and brain tissue' resource to SPOTRIAS investigators at UCLA, and a larger network of investigators with interests in the treatment of acute ischemic and hemorrhagic stroke.
描述(由申请人提供):该中心将作为血液和组织研究的重要资源中心,这些研究是完成与脑出血和缺血性梗塞的侵略性介入治疗相关的研究项目所不可或缺的。它将为研究患者的血液和组织分析带来与中风发病机制相关的形态解剖学技术方面的丰富专业知识,并为主要研究人员提供从研究患者的活检和尸检样本中提取的脑组织样本的途径。该核心将支持项目1,即磁共振抢救试验,在该试验中,血管内血栓材料将在治疗性血栓切除过程中被移除。该核心将帮助研究人员研究血栓形成的生化机制,以及它在脑梗塞演变中的可能重要性,并将帮助研究人员将他们的发现与血栓的光学显微镜/超微结构特征相关联。核心也将
为项目2提供支持,即血红素手术试验,在该试验中,脑组织起源于血块
对自发性脑(实质)出血患者进行的疏散将仔细评估出血的可能原因和对脑内血液的组织反应,并为利用定性、实时RT-PCR和基因芯片研究差异基因表达做好准备。核心中心将存储适当患者的血液样本用于DNA分析,并在适当审查他们的研究目标和项目后将这些样本提供给研究人员。该中心将作为加州大学洛杉矶分校SPOTRIAS研究人员的重要“血液和脑组织”资源,以及对急性缺血性和出血性中风的治疗感兴趣的更大的研究人员网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARRY V. VINTERS其他文献
HARRY V. VINTERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARRY V. VINTERS', 18)}}的其他基金
Cerebral Amyloid Angiopathy and Related Cerebral Microvasculopathies
脑淀粉样血管病及相关脑微血管病
- 批准号:
7805687 - 财政年份:2009
- 资助金额:
$ 16.51万 - 项目类别:
相似海外基金
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10722686 - 财政年份:2023
- 资助金额:
$ 16.51万 - 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
- 批准号:
10571353 - 财政年份:2023
- 资助金额:
$ 16.51万 - 项目类别:
Elucidation of changes in electrical properties during the blood coagulation process and its use for measurement of blood coagulation status during extracorporeal circulation
阐明血液凝固过程中电特性的变化及其在体外循环期间血液凝固状态测量中的应用
- 批准号:
23K08266 - 财政年份:2023
- 资助金额:
$ 16.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Innovative Platform for Low Volume Blood Coagulation Analysis
SBIR II 期:低容量凝血分析的创新平台
- 批准号:
2134020 - 财政年份:2022
- 资助金额:
$ 16.51万 - 项目类别:
Cooperative Agreement
Construction of a multilayered network to represent blood coagulation process
构建代表血液凝固过程的多层网络
- 批准号:
22K12252 - 财政年份:2022
- 资助金额:
$ 16.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
- 批准号:
10616732 - 财政年份:2022
- 资助金额:
$ 16.51万 - 项目类别:
Development of thrombus prevention technology for ECMO devices based on the blood coagulation mechanism caused by viral infections
基于病毒感染凝血机制的ECMO装置血栓预防技术开发
- 批准号:
21K08817 - 财政年份:2021
- 资助金额:
$ 16.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10452687 - 财政年份:2021
- 资助金额:
$ 16.51万 - 项目类别:
SBIR Phase II: CoagCare-A POC Blood Coagulation Diagnostic Platform That Utilizes A Hand-held Meter and Mechanically Sensitive Test Strips for Broad Spectrum Hemostasis Monitoring
SBIR II 期:CoagCare - POC 凝血诊断平台,利用手持式仪表和机械敏感试纸条进行广谱止血监测
- 批准号:
2050272 - 财政年份:2021
- 资助金额:
$ 16.51万 - 项目类别:
Cooperative Agreement
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10283268 - 财政年份:2021
- 资助金额:
$ 16.51万 - 项目类别:














{{item.name}}会员




